New type of cell division discovered

December 17, 2012

Researchers testing a theory about how a cell divides and how cancer begins have discovered a new type of cell division, the fundamental process by which cells replicate, Mark Burkard, MD, PhD, reported at the American Society for Cell Biology Annual Meeting, Dec. 17 in San Francisco.

The new type of cell division, which the researchers named klerokinesis, could be an evolutionary failsafe mechanism that could rescue a range of cell functions during embryonic development to genetic repair that can become abnormal if cell division fails to produce normal cells, said Dr. Burkard of the University of Wisconsin, Madison. "We hope to learn how to promote klerokinesis to help prevent cancer," he added.

Numerous cell divisions occur once a single egg is fertilized. The number of mitotic cycles is estimated at ~1013, about 25 times the number of stars in our galaxy, according to Dr. Burkard. Beyond number, accuracy also counts in mitosis and was an early concern of Theodor Boveri, PhD, the German cell biology pioneer who in 1914 published the hypothesis that mistakes that occur when chromosomes divide during the mitotic cell cycle would lead to aneuploidy, characterized by too many or too few chromosomes in the resulting daughter cells. Such abnormal cells, Dr. Boveri believed, would lead to the out-of-control cell division that is a hallmark of cancer.

During the almost 100 years since Dr. Boveri's hypothesis was published, cell biologists have found considerable evidence that aneuploidy can promote the transformation of normal cells into cancer. Until the recent arrival of live single-cell videomicroscopy techniques, Dr. Burkard explained, it wasn't possible to examine a key feature of Boveri's theory: that aneuploidy results from the failure of cytokinesis, the separation of the cell membrane between segregated chromosomes to form two daughter cells.

Dr. Burkard and Wisconsin colleagues allowed human retinal pigment epithelial (RPE) cells in the lab to undergo karyokinesis, the orderly separation of chromosomes in mitosis, but blocked cytokinesis, the actual division into two daughter cells. This process resulted in single cells with two nuclei, termed binucleate. Binucleate cells were allowed to go through more mitotic cycles and proliferate.

The researchers said that they were surprised that one-third of the binucleate cells generated healthy daughter colonies. In addition, the majority of their progeny had chromosome sets that perfectly matched the original first-generation RPE cell. "This made Boveri's random chromosome assortment seem rather improbable," Dr. Burkard explained, "so we carefully observed the cells by time-lapse microscopy to see how this might be occurring."

They discovered that cells with two nuclei got stuck in the first growth phase of the cell cycle long enough for them to stretch apart, dividing the cytoplasm into two cells, each with its own nucleus. The process neatly preserved the accurately separated chromosome sets. Further work showed that these cells managed to divide without the usual proteins required for division of cell membranes in cytokinesis.

"We concluded that we were observing a new type of cell division," Dr. Burkard said, "which we term 'klerokinesis.' Klerokinesis is derived from the Greek root for allotted inheritance, chosen because each daughter inherits a full set of chromosomes. Klerokinesis is a primitive mechanism of cell division that appears to be preserved in humans, as similar divisions have been observed in organisms such as slime molds, he added.
The American Cancer Society, Mary Kay Foundation, and National Institutes of Health funded this research.


Mark Burkard, MD, PhD.
University of Wisconsin, 608-262-2803

University of Wisconsin press contact:

Toni Angela Morrissey

ASCB press contacts:

John Fleischman, 513-706-0212

Cathy Yarbrough, 858-243-1814


"Interphase fission maintains genomic integrity after failure of cytokinesis in human cells," Monday, Dec.17, 2012, 2-3:30 pm, Session: Cytokinesis II, poster: B328, presentation: 1079, Exhibit Halls A-C

American Society for Cell Biology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to